Cronos Group Inc. (CRON) Key Metrics

NASDAQ: CRONValuation, returns, debt and efficiency ratios over 10 years.

CRON valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$1.18B
Enterprise value
$464.0M
P/E (TTM)
16.9
10-yr median 19.0
Forward P/E
28.7
PEG ratio
—
Price / sales
6.6
10-yr median 37.4
Price / book
1.2
10-yr median 1.3
EV / EBITDA
51.5
Dividend yield
—
Beta
1.20

CRON key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

CRON valuation Price multiples at each fiscal year-end price.

Price / sales+2.6%
6.8
2025 · hover or tap a bar for each year
2016: 209.32017: 329.9 (+57.6%)2018: 147.7 (−55.2%)2019: 147.4 (−0.2%)2020: 52.2 (−64.6%)2021: 22.5 (−56.9%)2022: 11.0 (−50.9%)2023: 9.1 (−17.3%)2024: 6.6 (−27.4%)2025: 6.8 (+2.6%)
20162025
Price / book+26.6%
0.9
2025 · hover or tap a bar for each year
2016: 3.42017: 15.6 (+353.2%)2018: 12.1 (−22.7%)2019: 2.0 (−83.4%)2020: 1.4 (−28.7%)2021: 1.1 (−23.8%)2022: 0.8 (−22.9%)2023: 0.7 (−13.5%)2024: 0.7 (+1.1%)2025: 0.9 (+26.6%)
20162025
Free cash flow yield−0.7 pts
0.0%
2025 · hover or tap a bar for each year
2016: −6.9%2017: −2.8% (+4.1 pts)2018: −5.1% (−2.3 pts)2019: −4.8% (+0.3 pts)2020: −7.4% (−2.6 pts)2021: −11.4% (−4.0 pts)2022: −9.8% (+1.6 pts)2023: −5.8% (+4.0 pts)2024: 0.7% (+6.5 pts)2025: 0.0% (−0.7 pts)
20162025

CRON valuation history

Fiscal year-endToday10-year median

CRON returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

CRON debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

CRON cash returned to shareholders

DividendsBuybacksFree cash flow

CRON price vs earnings per share

Share price at year-endEPS (right axis)

CRON key metrics

2016–2025
Cronos Group Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$1.01B$778.8M$796.2M$957.5M$1.45B$2.44B$2.63B$1.79B$1.37B$86.3M
Enterprise value$183.1M−$78.0M−$62.8M$83.6M$457.1M$1.16B$1.50B$1.76B$1.36B$86.7M
P/E ratio—19.0————2.2—540.6—
Price / sales6.86.69.111.022.552.2147.4147.7329.9209.3
Price / book0.90.70.70.81.11.42.012.115.63.4
Price / free cash flow—136.9————————
Price / operating cash flow38.541.3————————
EV / sales1.2-0.7-0.71.07.124.884.3145.0329.2210.2
Earnings yield−0.9%5.3%−9.3%−17.6%−27.3%−3.0%45.4%−1.2%0.2%−1.4%
Free cash flow yield0.0%0.7%−5.8%−9.8%−11.4%−7.4%−4.8%−5.1%−2.8%−6.9%
Dividend yield——0.0%0.0%—0.1%2.5%0.0%0.0%0.0%
Shareholder yield (dividends + buybacks)1.0%0.0%0.2%0.4%1.2%0.2%2.5%0.0%0.0%0.0%
Share price at fiscal year-end$2.63$2.02$2.09$2.54$3.92$6.94$7.67$10.39$7.73$1.10
Per share
Revenue per share$0.39$0.31$0.23$0.23$0.17$0.13$0.05$0.07$0.02$0.01
Earnings per share−$0.02$0.11−$0.19−$0.45−$1.07−$0.21$3.48−$0.13$0.01−$0.02
Operating cash flow per share$0.07$0.05−$0.11−$0.24−$0.41−$0.41−$0.28−$0.06−$0.02−$0.06
Free cash flow per share$0.00$0.01−$0.12−$0.25−$0.45−$0.51−$0.37−$0.53−$0.22−$0.08
Cash per share$2.16$2.23$2.26$2.33$2.71$3.67$3.30$0.19$0.04$0.03
Book value per share$2.84$2.76$2.89$3.03$3.61$4.87$3.83$0.86$0.50$0.32
Tangible book value per share$2.64$2.57$2.83$2.96$3.56$4.16$3.21$0.81$0.44$0.20
Dividends per share——$0.00$0.00—$0.01$0.19$0.00$0.00$0.00
Capex per share$0.07$0.03$0.01$0.01$0.03$0.10$0.09$0.49$0.19$0.01
Debt per share$0.00$0.01$0.01$0.01$0.03$0.03$0.02$0.00$0.02$0.04
Shares outstanding385.3M385.6M381.0M377.0M370.4M351.6M342.8M172.3M176.8M78.2M
Change in shares outstanding−0.1%+1.2%+1.1%+1.8%+5.4%+2.6%+99.0%−2.6%+125.9%—
Returns & profitability
Return on equity (ROE)−0.9%3.8%−6.6%−13.6%−26.0%−4.8%163.2%−18.3%4.5%−7.2%
Return on invested capital (ROIC)−6.0%−34.2%−26.2%−28.7%−59.6%−55.9%−77.8%−16.1%−11.2%−9.8%
Return on assets (ROA)−0.8%3.6%−6.3%−12.9%−23.8%−4.2%132.5%−13.9%4.5%−5.6%
Return on tangible assets−0.9%3.8%−6.6%−14.2%−28.7%−4.4%88.1%−9.7%3.6%−5.4%
Free cash flow margin0.1%4.8%−53.0%−108.3%−256.9%−385.8%−711.4%−754.2%−926.4%—
Income quality (OCF / net income)—0.46————−0.08—−1.75—
Financial health
Total debt$1.5M$2.0M$2.6M$3.9M$9.8M$9.8M$5.3M$159,292$4.3M$3.0M
Cash & short-term investments$831.8M$858.8M$861.5M$877.7M$1.00B$1.29B$1.13B$32.7M$7.3M$2.6M
Net debt−$830.3M−$856.8M−$859.0M−$873.8M−$994.9M−$1.28B−$1.13B−$32.5M−$3.1M$398,626
Debt / equity0.000.000.000.000.010.010.000.000.050.12
Debt / assets0.000.000.000.000.010.010.000.000.050.09
Current ratio19.5918.8422.5414.1019.866.634.731.523.391.04
Quick ratio18.6218.1721.8113.5419.256.424.611.211.850.56
Interest coverage——————-4.8-260.3-77.7-8.9
Working capital$895.9M$886.4M$891.9M$892.0M$1.03B$1.17B$931.6M$17.2M$15.0M$238,539
Invested capital$263.6M$207.3M$240.6M$270.0M$342.4M$431.4M$188.5M$115.9M$84.5M$25.5M
Tangible asset value$1.07B$1.04B$1.07B$1.11B$1.32B$1.46B$1.10B$187.4M$58.3M$15.4M
Net current asset value$889.9M$880.8M$889.2M$888.1M$1.02B$1.15B$925.2M$15.6M$9.6M−$845,458
Graham number—$2.57————$17.33—$0.40—
Graham net-net per share$2.19$2.18$2.26$2.25$2.65$3.17$2.62$0.03$0.02−$0.04
Capital allocation
Dividends paid——$345,000$384,000—$2.6M$65.1M$0$0$0
Share buybacks (net)$9.9M$0$1.4M$3.8M$17.0M$2.7M$1.2M$0$0$0
Dividend payout ratio——————5.5%—0.0%—
Dividends + buybacks / free cash flow—0.0%————————
Capex / revenue17.5%11.2%3.9%5.8%19.0%75.8%164.0%695.2%819.9%274.8%
Capex / operating cash flow99.4%69.8%————————
Capex / depreciation1.811.410.420.380.805.028.9643.5042.873.98
Stock-based compensation / revenue4.7%7.4%10.1%17.4%15.7%32.9%48.9%25.7%35.8%55.4%
R&D / revenue3.0%3.6%6.7%15.1%33.8%43.6%51.2%14.2%56.7%569.9%
SG&A / revenue42.8%65.3%92.8%116.1%188.5%278.9%489.0%198.3%168.9%675.2%
Efficiency
Days sales outstanding106.4101.9140.5135.9167.7150.2169.7117.4164.890.5
Days of inventory on hand166.7125.7164.9180.1170.6182.6227.2609.61,132.4347.3
Days payables outstanding59.757.556.457.067.7115.4165.2242.9625.2170.3
Cash conversion cycle (days)213.4170.1249.0258.9270.7217.4231.6484.2671.9267.5
Receivables turnover3.433.582.602.692.182.432.153.112.224.03
Payables turnover6.116.356.476.405.393.162.211.500.582.14
Inventory turnover2.192.902.212.032.142.001.610.600.321.05
Asset turnover0.130.100.070.070.040.030.020.080.070.02
Average receivables$43.5M$32.8M$33.6M$32.3M$29.7M$19.2M$8.3M$3.9M$1.9M$102,246
Average payables$14.3M$14.6M$11.6M$11.1M$15.2M$22.9M$14.1M$3.9M$3.4M$675,647
Average inventory$39.9M$31.8M$34.0M$35.2M$38.4M$36.3M$19.3M$9.9M$6.2M$1.4M
Intangibles / total assets6.3%6.4%1.9%2.3%1.4%12.9%13.7%4.1%12.9%30.3%

Computed from CRON's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

CRON valuation and financial ratios

Based on the latest twelve months, the trailing P/E is 16.9 and the forward P/E is 28.7. Cronos earned a return on equity of −0.9% and a return on invested capital of −6.0% in fiscal 2025. It ended the year with $1.5 million of debt and $831.8 million in cash and short-term investments, a net cash position of $830.3 million. It returned $9.9 million to shareholders: $0 in dividends and $9.9 million in share buybacks. The share count rose 392.4% from 78.2M to 385.3M over 9 years.

See the CRON income statement, the CRON chart for price history, or the CRON stock overview for the latest quote and news.

CRON key metrics FAQ

What is Cronos's P/E ratio?

Cronos's trailing P/E ratio is 16.9 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 28.7. At the end of fiscal 2025 it was —, compared with a 10-year median of 19.0.

What is Cronos's return on equity?

Cronos's return on equity (ROE) was −0.9% in fiscal 2025: net income of -$9.6 million on average shareholders' equity of $1.1 billion.

What is Cronos's ROIC?

Cronos's return on invested capital was −6.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Cronos have?

Cronos had total debt of $1.5 million at the end of fiscal 2025, a debt-to-equity ratio of 0.00 and more cash than debt.

Does Cronos buy back its shares?

Yes. Cronos spent $9.9 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.1% over the year, to 385.3M..

What is Cronos's free cash flow yield?

Cronos generated $0.2 million of free cash flow in fiscal 2025, a free cash flow yield of 0.0% on its market value at year-end ($1.0 billion).

What is Cronos's current ratio?

Cronos's current ratio was 19.59 at the end of fiscal 2025: current assets were 19.59 times current liabilities.

Drug Manufacturers - Specialty & Generic key metrics